SERVICES
Urologic Oncology
Prostate Cancer
At Aevum Performance & Urology, Dr. A. Lloyd Osbourne brings nearly two decades of surgical experience and advanced fellowship training in Robotic Urologic Oncology, via Harvard Mass General & Tufts, to deliver precision, safety, and discretion in personalized prostate cancer care.
​
Using the most advanced robot-assisted surgical platforms, Dr. Osbourne combines expert technique with an individualized, concierge-level approach. His focus extends beyond cancer removal—he prioritizes nerve preservation, continence, and sexual function, ensuring that each procedure is tailored to maximize quality of life maintenance.
​
Dr. Osbourne employs refined graded nerve-sparing techniques and advanced intra-operative margin assessment, including the NeuroSAFE protocol, which allows real-time frozen-section analysis to confirm clean margins while preserving vital nerves. This approach has been shown to significantly increase successful bilateral nerve-sparing without compromising oncologic outcomes (Schlomm et al., Eur Urol 2012; van der Slot et al., BJU Int 2022; Kroon et al., Eur Urol Oncol 2024; Dinneen et al., Lancet Oncol 2025).
​
Recent data demonstrate that men undergoing modern robotic prostatectomy achieve >90% urinary continence and strong erectile-function recovery when nerve preservation is feasible (Coughlin et al., J Urol 2007; Kang et al., Investig Clin Urol 2020).
​
At Aevum, every detail of your care—from consultation through recovery—is designed to reflect a high-touch, modern, and outcome-driven experience, combining leading-edge technology with the skill and artistry of a surgeon devoted to excellence patient-centered outcomes.
Urologic Oncology
Renal Cancer
At Aevum, Dr. Osbourne offers advanced, precision-based care for patients with kidney tumors with a focus on organ preservation.
​
The robot-assisted partial nephrectomy (RAPN) technique allows for meticulous removal of renal cell carcinoma while preserving as much healthy kidney tissue as possible. Using state-of-the-art robotic instrumentation and magnified 3-D visualization, Dr. Osbourne performs complex resections through minimally invasive incisions, ensuring both cancer control and renal preservation.
​
Extensive research confirms that RAPN achieves oncologic outcomes equivalent to open surgery, while offering superior kidney function preservation, shorter recovery times, and reduced postoperative discomfort (Zargar et al., Eur Urol 2016; Mir et al., J Urol 2017). In expert hands, warm ischemia times under 25 minutes and positive-margin rates below 3% are routinely achieved (Minervini et al., Eur Urol Oncol 2020; Mottrie et al., BJU Int 2021).
​
Through his deep experience and refined surgical technique, Dr. Osbourne blends oncologic precision with the artistry of minimally invasive care. At Aevum, every procedure reflects the clinic’s philosophy—to deliver excellence with compassion and the highest standard of modern robotic surgery.
